Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial - Reuters
Source: Reuters ·
Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial ReutersBristol Myers’ pivotal CAR-T multiple myeloma trial hits primary endpoint Fierce BiotechArlo-Cel Meets ORR End Point in BCMA-Pretreated, Quadruple-Class Exposed R/R Myeloma onclive.comArlocabtagene Autoleucel Meets Primary Endpoint in Phase 2 QUINTESSENTIAL Trial for Multiple Myeloma OncodailyBristol Myers Squibb stock…